In this study, we revealed that the expression of H19 is substantially upregulated in tamoxifen-resistant breast cancer cell line and tumor tissues, and silencing H19 sensitizes MCF7/TAMR cells to tamoxifen treatment both in vitro and in vivo. The gene discussed is H19; the disease is neoplasm.